Burlingame, CA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Global Poultry Antibiotic Market is estimated to be valued at USD 2.25 Bn in 2025 and is expected to reach USD 3.38 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 6% from 2025 to 2032. The poultry antibiotic market is witnessing steady growth driven by the increasing demand for poultry meat and eggs, rising concerns over animal health, and the need to prevent and treat bacterial infections in poultry. The expansion of commercial poultry farming and advancements in veterinary healthcare are further fueling market demand. However, growing awareness of antibiotic resistance and regulatory restrictions are prompting a shift toward alternative solutions, such as probiotics and organic feed additives. Despite these challenges, the market continues to evolve with innovations aimed at ensuring safe and sustainable poultry production.
Request Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/5709
Global Poultry Antibiotic Market Key Takeaways
According to Coherent Market Insights (CMI), the global poultry antibiotic market size is projected to grow steadily, reaching USD 2.25 Bn in 2025 and USD 3.38 Bn by 2032.
Global demand for poultry antibiotics is slated to rise at a CAGR of 6% during the forecast period.
Penicillins are expected to remain the top-selling product type, accounting for more than one-third of the global poultry antibiotic market share in 2025.
North America is the undisputed leader in the global poultry antibiotic industry, accounting for 43.2% of the market share in 2025.
Europe, with an estimated 30% market share, remains the second-largest consumer of poultry antibiotics.
Asia Pacific is expected to emerge as a hotbed for poultry antibiotic companies during the forecast period.
Rising Poultry Demand Spurring Market Growth
Coherent Market Insights’ latest poultry antibiotic market report highlights major factors driving industry growth. Increasing demand for poultry products is one such prominent growth driver.
Rapid population growth and urbanization are leading to higher consumption of poultry meat and eggs. For instance, OECD and FAO estimate that total poultry meat consumption will likely reach 91 million tons by 2032.
To meet this growing demand, poultry farms are intensifying production, which increases the need for antibiotics to prevent disease outbreaks as well as minimize livestock losses. Consequently, growing demand for poultry is expected to support expansion of the poultry antibiotics market.
Purchase Now Up to 25% Discount on This Premium Report: https://www.coherentmarketinsights.com/insight/buy-now/5709
Rising Concerns Over Antimicrobial Resistance (AMR) Hampering Market Growth
The future poultry antibiotic market outlook appears positive. However, growing concerns over antimicrobial resistance present a significant challenge to widespread market expansion.
Excessive use of antibiotics in poultry has been linked to emergence of antimicrobial resistance, a major public health concern globally. In response, governments and regulatory bodies in various countries have introduced stringent regulations and guidelines to limit or ban the use of antibiotics, especially as growth promoters in livestock.
Consequently, many poultry producers are shifting toward alternatives like probiotics, prebiotics, phytogenics, and enzymes to maintain animal health and productivity. This shifting preference is likely to limit overall poultry antibiotic market demand during the assessment period.
Increasing Incidence of Poultry Diseases Creating Lucrative Growth Opportunities
The rising prevalence of poultry diseases like bacterial infections, avian influenza, coccidiosis, and infectious bronchitis is a significant concern in the global poultry industry. This increase is expected to boost demand for antibiotics for both therapeutic and preventive purposes, thereby creating lucrative growth opportunities for the poultry health market.
Emerging Poultry Antibiotic Market Trends
A key trend in the poultry antibiotic market is the development of new formulations. Leading companies are striving to develop novel antibiotic formulations with better efficacy and reduced side effects.
Adoption of intensive poultry farming practices is contributing to expansion of the poultry antibiotics market. High stocking densities and confined conditions in large-scale commercial poultry operations increase the risk of disease outbreaks. This, in turn, drives demand for regular antibiotic use to prevent and treat infections.
Usage of antibiotics in some regions for improved feed efficiency and growth promotion is boosting the market. Many poultry farmers use certain antibiotics to enhance weight gain and feed conversion efficiency.
Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/5709
Analyst’s View
“The global poultry antibiotic industry is poised to grow steadily, owing to rising prevalence of poultry diseases, growing demand for poultry products, and advancement in veterinary healthcare,” said senior CMI analyst Vipul Patil.
Current Events and Their Impact on the Poultry Antibiotic Market
| Event | Description and Impact |
| Mid-2025 Avian Influenza Resurgence in Europe & Asia |
|
| India’s Ban on Colistin in Poultry Feed (2025) |
|
| Rising Prevalence of Bacterial Poultry Diseases |
|
Competitor Insights
Key companies listed in the poultry antibiotic market research report:
- Bayer AG
- Elanco Animal Health
- Zoetis Inc.
- Boehringer Ingelheim Animal Health
- Merck & Co. Inc.
- Ceva Santé Animale
- Neogen Corporation
- Vetoquinol S.A.
- Virbac
- Phibro Animal Health Corporation
- Huvepharma
- Nisseiken Co., Ltd.
- Inovio Pharmaceuticals, Inc.
- Venkys India Ltd.
Key Developments
In July 2025, Merck Animal Health received FDA approval for EXZOLT, an oral solution designed for chickens. This innovative treatment provides a safe and effective way to combat northern fowl mite infestations in poultry.
In June 2024, Virbac solidified its position in India by completing the acquisition of Globion, a prominent poultry vaccine specialist. This acquisition will significantly expand Virbac India’s poultry portfolio.
Market Segmentation:
- By Product Type:
- Penicillins
- Tetracyclines
- Macrolides
- Lincosamides
- Aminoglycosides
- Others (Fluoroquinolones, etc.)
- By Mode of Administration:
- Oral
- Injection
- Others
- By Distribution Channel:
- Veterinary Pharmacies
- Online Channel
- Others (feed stores, etc.)
- By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Read More Reports:
Poultry Diagnostics Market Size, Share & Trend Analysis Report for 2025-2032
Poultry Vaccine Market Analysis and Forecast for 2025-2032
Poultry Pharmaceuticals Market Size, Share, Trends & Opportunities for 2025-2032
Our Trusted Partners:
Worldwide Market Reports, Coherent MI, Stratagem Market Insights
Get Recent News:
https://www.coherentmarketinsights.com/news
About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com For Latest Update Follow Us: LinkedIn | Facebook | Twitter
